52 North Health
Medtech startup which has developed a device that allows patients to monitor themselves for potentially life-threatening side effects of chemotherapy
52 North Health has raised €2.6M across 2 funding rounds from 7 investors, most recently a Grant round in Nov 2022. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.
Cambridge, UKwww.52north.health ↗
Total raised
€2.6M
€2,574,923
Funding rounds
2
Investors
7
distinct backers
Active since
2022-04
latest 2022-11
Funding by year
EUR raised per year52 North Health — funding by year — interactive chart.
Data table
| 52 North Health — funding by year | |
|---|---|
| 2022 | €2.6M |
Signals
High confidenceRaise-next likelihood9
base rate 45% for Grant
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-11-23 | Grant | €1.4M | Innovate UK | View deal → |
| 2022-04-28 | Other | €1.2M | Angel Investors,Cambridge Enterprise,Crista Galli Ventures,King’s Health Partners MedTech Innovations,Meltwind,Milltrust Ventures | View deal → |
Investors
7Related news
- Medtech startup 52 North Health scales up its mission to improve chemotherapy treatmentseu-startups.com · 2022-11
- 52 North Health gets £1 million shot to boost affordable cancer caretech.eu · 2022-04
- Cambridge medtech founded by husband-wife duo picks £1M to monitor cancer chemotherapy riskstechfundingnews.com · 2022-04
Similar companies
same sector or countryGlobal coverage: FundingData